86 related articles for article (PubMed ID: 23334809)
1. Recurrent Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1 Syndrome.
Libánský P; Čarková J; Kushnir I; Matějková Běhanová M; Procyklová K; Šedý J; Vaculová M; Včelák J; Zikán V; Adámek S
Physiol Res; 2023 Dec; 72(S4):S423-S427. PubMed ID: 38116778
[TBL] [Abstract][Full Text] [Related]
2. Traits of Patients With Pituitary Tumors in Multiple Endocrine Neoplasia Type 1 and Comparing Different Mutation Status.
Lin KY; Kuo YT; Cheng MF; Chen PL; Wang HP; Cheng TY; Chang CH; Kao HF; Yang SH; Li HY; Lin CH; Chou YT; Chung AK; Wu WC; Lu JY; Wang CY; Hsih WH; Wen CY; Yang WS; Shih SR
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1532-e1541. PubMed ID: 37390813
[TBL] [Abstract][Full Text] [Related]
3. [Predicting the presence of
Mokrysheva NG; Eremkina AK; Miliutina AP; Salimkhanov RK; Aboishava LA; Bibik EE; Gorbacheva AM; Elfimova AR; Kovaleva EV; Popov SV; Melnichenko GA
Probl Endokrinol (Mosk); 2023 Nov; 69(5):4-15. PubMed ID: 37968947
[TBL] [Abstract][Full Text] [Related]
4. Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome.
Ruggeri RM; Benevento E; De Cicco F; Grossrubatscher EM; Hasballa I; Tarsitano MG; Centello R; Isidori AM; Colao A; Pellegata NS; Faggiano A
Endocrine; 2023 Dec; 82(3):480-490. PubMed ID: 37632635
[TBL] [Abstract][Full Text] [Related]
5. Genetic Testing in Hereditary Pituitary Tumors.
Akkuş G; Korbonits M
Arch Med Res; 2023 Dec; 54(8):102920. PubMed ID: 38007383
[TBL] [Abstract][Full Text] [Related]
6. [Tumor predisposition in endocrinology - from MEN to FIPA].
Jegodzinski L; Gebauer J
Dtsch Med Wochenschr; 2024 Mar; 149(6):283-289. PubMed ID: 38412983
[TBL] [Abstract][Full Text] [Related]
7. Whole-Exome Screening and Analysis of Signaling Pathways in Multiple Endocrine Neoplasia Type 1 Patients with Different Outcomes: Insights into Cellular Mechanisms and Possible Functional Implications.
Skalniak A; Trofimiuk-Müldner M; Surmiak M; Totoń-Żurańska J; Jabrocka-Hybel A; Hubalewska-Dydejczyk A
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256138
[TBL] [Abstract][Full Text] [Related]
8. Systematic detection of mosaicism by using digital NGS reveals three new MEN1 mosaicisms.
Lagarde A; Mougel G; Coppin L; Haissaguerre M; Le Collen L; Mohamed A; Klein M; Odou MF; Tabarin A; Brixi H; Cuny T; Delemer B; Barlier A; Romanet P
Endocr Connect; 2022 Nov; 11(11):. PubMed ID: 36112497
[TBL] [Abstract][Full Text] [Related]
9. Correction to: "Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review".
J Clin Endocrinol Metab; 2024 Mar; ():. PubMed ID: 38470411
[No Abstract] [Full Text] [Related]
10. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
[TBL] [Abstract][Full Text] [Related]
11. Clinical aspects of multiple endocrine neoplasia type 1.
Al-Salameh A; Cadiot G; Calender A; Goudet P; Chanson P
Nat Rev Endocrinol; 2021 Apr; 17(4):207-224. PubMed ID: 33564173
[TBL] [Abstract][Full Text] [Related]
12. Clinical MEN-1 Among a Large Cohort of Patients With Acromegaly.
Nachtigall LB; Guarda FJ; Lines KE; Ghajar A; Dichtel L; Mumbach G; Zhao W; Zhang X; Tritos NA; Swearingen B; Miller KK; Thakker RV
J Clin Endocrinol Metab; 2020 Jun; 105(6):e2271-81. PubMed ID: 32311048
[TBL] [Abstract][Full Text] [Related]
13. Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China.
Wu Y; Gao L; Guo X; Wang Z; Lian W; Deng K; Lu L; Xing B; Zhu H
Pituitary; 2019 Apr; 22(2):113-123. PubMed ID: 30637623
[TBL] [Abstract][Full Text] [Related]
14. Frequency of familial pituitary adenoma syndromes among patients with functioning pituitary adenomas in a reference outpatient clinic.
Marques NV; Kasuki L; Coelho MC; Lima CHA; Wildemberg LE; Gadelha MR
J Endocrinol Invest; 2017 Dec; 40(12):1381-1387. PubMed ID: 28689311
[TBL] [Abstract][Full Text] [Related]
15. Multiple Endocrine Neoplasia: Genetics and Clinical Management.
Norton JA; Krampitz G; Jensen RT
Surg Oncol Clin N Am; 2015 Oct; 24(4):795-832. PubMed ID: 26363542
[TBL] [Abstract][Full Text] [Related]
16. Frequency of multiple endocrine neoplasia type 1 in a group of patients with pituitary adenoma: genetic study and familial screening.
Nunes VS; Souza GL; Perone D; Conde SJ; Nogueira CR
Pituitary; 2014 Feb; 17(1):30-7. PubMed ID: 23334809
[TBL] [Abstract][Full Text] [Related]
17. Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese.
Tanaka C; Yoshimoto K; Yamada S; Nishioka H; Ii S; Moritani M; Yamaoka T; Itakura M
J Clin Endocrinol Metab; 1998 Mar; 83(3):960-5. PubMed ID: 9506756
[TBL] [Abstract][Full Text] [Related]
18. Multiple endocrine neoplasia type 1 in Poland: a two-centre experience.
Soczomski P; Jurecka-Lubieniecka B; Rogozik N; Tukiendorf A; Jarząb B; Bednarczuk T
Endokrynol Pol; 2019; 70(5):385-391. PubMed ID: 31274185
[TBL] [Abstract][Full Text] [Related]
19. [Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT].
Frank-Raue K; Leidig-Bruckner G; Lorenz A; Rondot S; Haag C; Schulze E; Büchler M; Raue F
Dtsch Med Wochenschr; 2011 Sep; 136(38):1889-94. PubMed ID: 21915802
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
